Patents expiring in 2031

US 7902239

Diaminotriazoles useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906484

Complex for transferring an anionic substance into a cell

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906628

Targeting proteins to deliver therapeutic or diagnostic reagents

The Board of Regents of the University of Texas System · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906638

Chimeric nucleic acids encoding polypeptides comprising CD70 and Fas ligand domains

The Regents of the University of California · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906962

Dynamic nuclear polarization enhanced nuclear magnetic resonance of water under ambient conditions

The Regents of the University of California · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906644

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906550

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906530

1,7-naphthyridine derivatives as p38 MAP kinase inhibitors

Laboratories Almirall, S.A. · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906535

High concentration topical insecticides containing pyrethroids

Summit VetPharm, LLC · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906491

Compounds for modulating the activity of exchange proteins directly activated by cAMP (Epacs)

Univisitair Medisch Centrum Utrecht · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906513

Hydrazide-containing hepatitis C serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906482

Anti-obesity agents

Advanced Diagnostics and Discovery · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906292

Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906650

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906523

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906555

Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7906104

Methods for detecting pancreatic beta-islet cells and diseases thereof

The Regents of the University of California · Granted Tue Mar 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2011062165

BALANCED INDIVIDUAL DINING PLATE

ALLERGAN INC [US] · Granted Thu Mar 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7910128

Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics

Supernus Pharmaceuticals, Inc. · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7910126

Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same

TEVA WOMEN'S HEALTH, INC. · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7908729

Method for making a lollipop

TEVA WOMEN'S HEALTH, INC. · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7910131

Method of treating seizures using modified release formulations of oxcarbazepine

Supernus Pharmaceuticals, Inc. · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7910105

Methods for treating and preventing fibrosis

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7910299

Methods for diagnosing systemic lupus erythematosus

Regents of the University of Minnesota · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7910323

Methods for identifying the effect of a drug agent on the metabolism of sugars and fats in an individual

The Regents of the University of California · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7910621

Small molecule antagonists of XIAP family proteins

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7910587

Quinoxalinyl dipeptide hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7910661

Thiol-selective water-soluble polymer derivatives

Nektar Therapeutics · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7910546

Methods and compositions for the treatment of gastrointestinal disorders

IRONWOOD PHARMACEUTICALS, INC. · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7910608

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7910692

Immunogenic peptides and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2011033094

CALENDRIER DE L'ADMINISTRATION DE DÉRIVÉS DE BENZAZOLE DANS LE TRAITEMENT DE LEUCÉMIES

4SC AG [DE] · Granted Thu Mar 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7915040

Defensin-antigen fusion proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7915267

Heterocyclic amide compound and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7914780

Aminopeptidase A (APA) targeting peptides for the treatment of cancer

The Board of Regents of the University of Texas System · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7914788

Monoclonal antibodies against orthopoxviruses

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7915036

Compositions comprising T cell receptors and methods of use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7915412

Process for the synthesis of 9-hydroxy risperidone (paliperidone)

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7915385

Sodium channel protein type III α-subunit splice variant

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7915423

Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7915396

Nucleic acid molecules encoding minimally immunogenic variants of SDR-grafted humanized antibody CC49

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7915285

Method for treating drug and behavioral addictions

The Regents of the University of Colorado · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7915273

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7915240

Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines

OM PHARMA · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7915215

Fragrance-delivery composition comprising boron and persulfate ion-crosslinked polyvinyl alcohol microcapsules and method of use thereof

Appleton Papers Inc. · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7915245

Methods and compositions of trail-death receptor agonists/activators

The Board of Regents of the University of Texas System · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7914801

Metabolizable oil emulsion adjuvants and vaccines for enhancing immuno-properties of antibodies and their subpopulations

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7915025

In vivo incorporation of unnatural amino acids

The Regents of the University of California · Granted Tue Mar 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)